Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 88

1.

Type I Interferon Signaling Prevents IL-1β-Driven Lethal Systemic Hyperinflammation during Invasive Bacterial Infection of Soft Tissue.

Castiglia V, Piersigilli A, Ebner F, Janos M, Goldmann O, Damböck U, Kröger A, Weiss S, Knapp S, Jamieson AM, Kirschning C, Kalinke U, Strobl B, Müller M, Stoiber D, Lienenklaus S, Kovarik P.

Cell Host Microbe. 2016 Mar 9;19(3):375-87. doi: 10.1016/j.chom.2016.02.003.

PMID:
26962946
2.

STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion.

Gotthardt D, Putz EM, Grundschober E, Prchal-Murphy M, Straka E, Kudweis P, Heller G, Bago-Horvath Z, Witalisz-Siepracka A, Cumaraswamy AA, Gunning PT, Strobl B, Müller M, Moriggl R, Stockmann C, Sexl V.

Cancer Discov. 2016 Apr;6(4):414-29. doi: 10.1158/2159-8290.CD-15-0732. Epub 2016 Feb 12.

PMID:
26873347
3.

Intestinal Microbiota Signatures Associated with Inflammation History in Mice Experiencing Recurring Colitis.

Berry D, Kuzyk O, Rauch I, Heider S, Schwab C, Hainzl E, Decker T, Müller M, Strobl B, Schleper C, Urich T, Wagner M, Kenner L, Loy A.

Front Microbiol. 2015 Dec 15;6:1408. doi: 10.3389/fmicb.2015.01408. eCollection 2015.

4.

The good and the bad faces of STAT1 in solid tumours.

Meissl K, Macho-Maschler S, Müller M, Strobl B.

Cytokine. 2015 Nov 26. pii: S1043-4666(15)30099-5. doi: 10.1016/j.cyto.2015.11.011. [Epub ahead of print] Review.

5.

Tyrosine kinase 2 - Surveillant of tumours and bona fide oncogene.

Leitner NR, Witalisz-Siepracka A, Strobl B, Müller M.

Cytokine. 2015 Nov 26. pii: S1043-4666(15)30086-7. doi: 10.1016/j.cyto.2015.10.015. [Epub ahead of print]

6.

In vivo tumor surveillance by NK cells requires TYK2 but not TYK2 kinase activity.

Prchal-Murphy M, Witalisz-Siepracka A, Bednarik KT, Putz EM, Gotthardt D, Meissl K, Sexl V, Müller M, Strobl B.

Oncoimmunology. 2015 May 26;4(11):e1047579. eCollection 2015 Nov.

7.

Intestinal Epithelial Cell Tyrosine Kinase 2 Transduces IL-22 Signals To Protect from Acute Colitis.

Hainzl E, Stockinger S, Rauch I, Heider S, Berry D, Lassnig C, Schwab C, Rosebrock F, Milinovich G, Schlederer M, Wagner M, Schleper C, Loy A, Urich T, Kenner L, Han X, Decker T, Strobl B, Müller M.

J Immunol. 2015 Nov 15;195(10):5011-24. doi: 10.4049/jimmunol.1402565. Epub 2015 Oct 2.

8.

Cooperative Transcriptional Activation of Antimicrobial Genes by STAT and NF-κB Pathways by Concerted Recruitment of the Mediator Complex.

Wienerroither S, Shukla P, Farlik M, Majoros A, Stych B, Vogl C, Cheon H, Stark GR, Strobl B, Müller M, Decker T.

Cell Rep. 2015 Jul 14;12(2):300-12. doi: 10.1016/j.celrep.2015.06.021. Epub 2015 Jul 2.

9.

Myeloid STAT3 promotes formation of colitis-associated colorectal cancer in mice.

Pathria P, Gotthardt D, Prchal-Murphy M, Putz EM, Holcmann M, Schlederer M, Grabner B, Crncec I, Svinka J, Musteanu M, Hoffmann T, Filipits M, Berger W, Poli V, Kenner L, Bilban M, Casanova E, Müller M, Strobl B, Bayer E, Mohr T, Sexl V, Eferl R.

Oncoimmunology. 2015 Jan 22;4(4):e998529. eCollection 2015 Apr.

10.

Noncanonical Effects of IRF9 in Intestinal Inflammation: More than Type I and Type III Interferons.

Rauch I, Rosebrock F, Hainzl E, Heider S, Majoros A, Wienerroither S, Strobl B, Stockinger S, Kenner L, Müller M, Decker T.

Mol Cell Biol. 2015 Jul;35(13):2332-43. doi: 10.1128/MCB.01498-14. Epub 2015 Apr 27.

11.

Methods to study tumor surveillance using tumor cell transplantation into genetically engineered mice.

Bauer E, Witalisz A, Strobl B, Stoiber D.

Methods Mol Biol. 2015;1267:439-56. doi: 10.1007/978-1-4939-2297-0_22.

PMID:
25636483
12.

Promoter occupancy of STAT1 in interferon responses is regulated by processive transcription.

Wiesauer I, Gaumannmüller C, Steinparzer I, Strobl B, Kovarik P.

Mol Cell Biol. 2015 Feb;35(4):716-27. doi: 10.1128/MCB.01097-14. Epub 2014 Dec 15.

13.

Interruption of macrophage-derived IL-27(p28) production by IL-10 during sepsis requires STAT3 but not SOCS3.

Bosmann M, Russkamp NF, Strobl B, Roewe J, Balouzian L, Pache F, Radsak MP, van Rooijen N, Zetoune FS, Sarma JV, Núñez G, Müller M, Murray PJ, Ward PA.

J Immunol. 2014 Dec 1;193(11):5668-77. doi: 10.4049/jimmunol.1302280. Epub 2014 Oct 27.

14.

Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillance.

Gotthardt D, Putz EM, Straka E, Kudweis P, Biaggio M, Poli V, Strobl B, Müller M, Sexl V.

Blood. 2014 Oct 9;124(15):2370-9. doi: 10.1182/blood-2014-03-564450. Epub 2014 Sep 2.

15.

Type I interferons have opposing effects during the emergence and recovery phases of colitis.

Rauch I, Hainzl E, Rosebrock F, Heider S, Schwab C, Berry D, Stoiber D, Wagner M, Schleper C, Loy A, Urich T, Müller M, Strobl B, Kenner L, Decker T.

Eur J Immunol. 2014 Sep;44(9):2749-60. doi: 10.1002/eji.201344401. Epub 2014 Aug 25.

16.

Recovery from chemotherapy depends on STAT1 for replenishment of B lymphopoiesis.

Strobl B, Moriggl R.

J Leukoc Biol. 2014 Jun;95(6):849-51. doi: 10.1189/jlb.0114051. No abstract available.

17.

STAT1β is not dominant negative and is capable of contributing to gamma interferon-dependent innate immunity.

Semper C, Leitner NR, Lassnig C, Parrini M, Mahlakõiv T, Rammerstorfer M, Lorenz K, Rigler D, Müller S, Kolbe T, Vogl C, Rülicke T, Staeheli P, Decker T, Müller M, Strobl B.

Mol Cell Biol. 2014 Jun;34(12):2235-48. doi: 10.1128/MCB.00295-14. Epub 2014 Apr 7.

18.

Conditional ablation of TYK2 in immunity to viral infection and tumor surveillance.

Vielnascher RM, Hainzl E, Leitner NR, Rammerstorfer M, Popp D, Witalisz A, Rom R, Karaghiosoff M, Kolbe T, Müller S, Rülicke T, Lassnig C, Strobl B, Müller M.

Transgenic Res. 2014 Jun;23(3):519-29. doi: 10.1007/s11248-014-9795-y. Epub 2014 Apr 3.

PMID:
24696087
19.

Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27.

Bosmann M, Strobl B, Kichler N, Rigler D, Grailer JJ, Pache F, Murray PJ, Müller M, Ward PA.

J Leukoc Biol. 2014 Jul;96(1):123-31. doi: 10.1189/jlb.3A1013-541R. Epub 2014 Mar 6.

20.

Inducible, dose-adjustable and time-restricted reconstitution of STAT1 deficiency in vivo.

Leitner NR, Lassnig C, Rom R, Heider S, Bago-Horvath Z, Eferl R, Müller S, Kolbe T, Kenner L, Rülicke T, Strobl B, Müller M.

PLoS One. 2014 Jan 29;9(1):e86608. doi: 10.1371/journal.pone.0086608. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk